| Literature DB >> 24995346 |
Yunsong Shen1, Danfeng Cao2, Yalin Li1, J K Kulski3, Lei Shi2, Hongjun Jiang1, Qianli Ma4, Jiankun Yu2, Jingxian Zhou2, Yufeng Yao2, Li Shi2.
Abstract
We investigated polymorphisms of the human leukocyte antigen (HLA) class I (A, B, and C) loci of a Han population (n, 239) from the Yunnan province, Southwest China, using high-resolution polymerase chain reaction-Luminex (PCR-Luminex) typing. We combined the HLA data from this study with the KIR genotypes from a previous study of this Han population to analyze the combination of KIR/HLA ligands. A total of 27 HLA-A, 54 HLA-B, and 31 HLA-C alleles were found in this population. The frequencies of A*11:01, A*24:02, B*40:01, B*46:01, C*01:02, C*03:04, and C*07:02 were all > 10%. The following haplotypes were common, with frequencies > 5%: 1 A-B (A*02:07-B*46:01), 2 A-C (A*02:07-C*01:02, and A*11:01-C*07:02), 4 C-B (B*13:01-C*03:04, B*40:01-C*07:02, B*46:01-C*01:02 and B*58:01-C*03:02), and 1 A-C-B (A*02:07-C*01:02-B*46:01). Analysis of KIR3D and their ligands HLA-A3/A11 and HLA-Bw4 showed that the frequencies of 3DL2(+)-A3/A11(+) and 3DL2(+)-A3/A11(-) were 0.527 and 0.473, and the frequencies of 3DL1(+)-Bw4(+), 3DL1(+)-Bw4(-), 3DL1(-)-Bw4(+), and 3DL1(-)-Bw4(-) were 0.552, 0.397, 0.038, and 0.013, respectively. The results of KIR/HLA-C combination analysis showed that all individuals had at least one inhibitory or activating KIR/HLA-C pair, and one KIR/HLA-C pair was the most frequent (157/239), followed by two pairs (46/239), three pairs (33/239), and no pairs (3/239). Comparison of KIR gene and HLA gene and their pair frequency between Yunnan Han and the isolated Han (FYDH) who also lived in Yunnan province showed no significant difference (P > 0.05) in KIR frequencies, but significant differences (P < 0.05) for some HLA allele frequencies. In addition, there was no significant difference (P > 0.05) between the two populations for KIR/HLA pairs.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24995346 PMCID: PMC4068047 DOI: 10.1155/2014/565296
Source DB: PubMed Journal: J Immunol Res ISSN: 2314-7156 Impact factor: 4.818
The Hardy-Weinberg's equilibrium observe heterozygosity, expect heterozygosity and Ewens-Watterson test of neutrality for HLA-A, -B, and -C loci in Yunnan Han.
| Alleles | Observe | Expect | H-W | E-W | |
|---|---|---|---|---|---|
| A | 27 | 0.858 | 0.861 | 0.148 | 0.609 |
| C | 31 | 0.920 | 0.941 | 0.162 | 0.355 |
| B | 54 | 0.866 | 0.900 | 0.255 | 0.528 |
HLA-A, HLA-B, and HLA-C allele frequencies in Yunnan Han.
| HLA-A | Frequency | HLA-B | Frequency | HLA-B | Frequency | HLA-C | Frequency |
|---|---|---|---|---|---|---|---|
| A*01:01 | 0.027 | B*07:02 | 0.013 | B*40:01 | 0.117 | C*01:02 | 0.203 |
| A∗02:01 | 0.086 | B*07:05 | 0.004 | B*40:02 | 0.010 | C*01:03 | 0.002 |
| A*02:03 | 0.040 | B*08:01 | 0.006 | B*40:06 | 0.019 | C*01:10 | 0.002 |
| A*02:04 | 0.006 | B*13:01 | 0.084 | B*44:02 | 0.013 | C*02:02 | 0.004 |
| A*02:05 | 0.002 | B*13:02 | 0.029 | B*44:03 | 0.027 | C*03:02 | 0.059 |
| A*02:06 | 0.052 | B*14:02 | 0.002 | B*46:01 | 0.144 | C*03:03 | 0.059 |
| A*02:07 | 0.094 | B*15:01 | 0.042 | B*47:01 | 0.002 | C*03:04 | 0.117 |
| A*02:10 | 0.002 | B*15:02 | 0.044 | B*48:01 | 0.021 | C*03:07 | 0.002 |
| A*03:01 | 0.025 | B*15:07 | 0.004 | B*48:03 | 0.004 | C*04:01 | 0.061 |
| A*03:02 | 0.002 | B*15:10 | 0.002 | B*49:01 | 0.002 | C*04:03 | 0.031 |
| A*11:01 | 0.268 | B*15:11 | 0.017 | B*50:01 | 0.004 | C*04:04 | 0.002 |
| A*11:02 | 0.006 | B*15:12 | 0.006 | B*51:01 | 0.031 | C*05:01 | 0.004 |
| A*11:05 | 0.002 | B*15:17 | 0.002 | B*51:02 | 0.006 | C*05:04 | 0.006 |
| A*23:01 | 0.004 | B*15:18 | 0.002 | B*52:01 | 0.031 | C*05:11 | 0.002 |
| A*24:02 | 0.190 | B*15:25 | 0.019 | B*52:05 | 0.002 | C*06:02 | 0.050 |
| A*24:03 | 0.004 | B*15:27 | 0.006 | B*52:06 | 0.002 | C*06:04 | 0.002 |
| A*24:07 | 0.006 | B*27:03 | 0.002 | B*54:01 | 0.040 | C*07:01 | 0.029 |
| A*26:01 | 0.019 | B*27:04 | 0.013 | B*55:02 | 0.025 | C*07:02 | 0.153 |
| A*29:01 | 0.004 | B*27:05 | 0.006 | B*56:01 | 0.002 | C*07:04 | 0.002 |
| A*30:01 | 0.031 | B*27:06 | 0.002 | B*56:02 | 0.004 | C*08:01 | 0.040 |
| A*31:01 | 0.017 | B*27:07 | 0.002 | B*57:01 | 0.006 | C*08:02 | 0.002 |
| A*32:01 | 0.010 | B*35:01 | 0.038 | B*57:08 | 0.002 | C*08:04 | 0.038 |
| A*33:01 | 0.002 | B*35:02 | 0.002 | B*58:01 | 0.054 | C*08:15 | 0.002 |
| A*33:03 | 0.086 | B*35:05 | 0.008 | B*67:01 | 0.004 | C*12:02 | 0.038 |
| A*68:01 | 0.006 | B*35:10 | 0.004 | B*78:01 | 0.004 | C*12:03 | 0.021 |
| A*69:01 | 0.004 | B*37:01 | 0.008 | B*78:02 | 0.002 | C*12:14 | 0.002 |
| A*74:01 | 0.002 | B*38:02 | 0.031 | C*14:02 | 0.038 | ||
| B*39:01 | 0.019 | C*14:03 | 0.002 | ||||
| C*14:06 | 0.002 | ||||||
| C*15:02 | 0.023 | ||||||
| C*15:04 | 0.002 |
Global linkage disequilibrium (D′ and Wn) values in Yunnan Han.
| Locus pair | D | D′ | Wn |
|
|---|---|---|---|---|
| A : B | 0.005 | 0.608 | 0.581 | <0.001 |
| A : C | 0.007 | 0.503 | 0.413 | <0.001 |
| B : C | 0.009 | 0.859 | 0.688 | <0.001 |
Common HLA A-C-B, A-B, A-C, and B-C haplotypes in Yunnan Han.
| A-C-B | Frequency | A-B | Frequency | A-C | Frequency | C-B | Frequency |
|---|---|---|---|---|---|---|---|
| A*02:01-C*01:02-B*46:01 | 0.011 | A*02:01-B*40:01 | 0.013 | A*01:01-C*06:02 | 0.014 | B*07:02-C*07:02 | 0.013 |
| A*02:03-C*07:02-B*38:02 | 0.010 | A*02:01-B*46:01 | 0.012 | A*02:01-C*01:02 | 0.025 | B*13:01-C*03:04 | 0.071 |
| A*02:07-C*01:02-B*46:01 | 0.067 | A*02:03-B*38:02 | 0.010 | A*02:01-C*03:04 | 0.015 | B*13:02-C*06:02 | 0.023 |
| A*11:01-C*01:02-B*46:01 | 0.029 | A*02:07-B*40:01 | 0.011 | A*02:01-C*07:02 | 0.015 | B*15:01-C*04:01 | 0.013 |
| A*11:01-C*01:02-B*54:01 | 0.012 | A*02:07-B*46:01 | 0.073 | A*02:03-C*01:02 | 0.010 | B*15:01-C*12:03 | 0.010 |
| A*11:01-C*03:04-B*13:01 | 0.031 | A*03:01-B*44:02 | 0.010 | A*02:03-C*07:02 | 0.018 | B*15:02-C*08:01 | 0.019 |
| A*11:01-C*03:04-B*40:01 | 0.018 | A*11:01-B*13:01 | 0.044 | A*02:06-C*08:01 | 0.010 | B*15:02-C*08:04 | 0.017 |
| A*11:01-C*07:02-B*40:01 | 0.023 | A*11:01-B*15:01 | 0.024 | A*02:07-C*01:02 | 0.068 | B*15:11-C*03:03 | 0.015 |
| A*11:01-C*08:01-B*15:02 | 0.014 | A*11:01-B*15:02 | 0.027 | A*11:01-C*01:02 | 0.050 | B*15:25-C*04:03 | 0.019 |
| A*11:01-C*12:02-B*52:01 | 0.010 | A*11:01-B*38:02 | 0.011 | A*11:01-C*03:03 | 0.013 | B*35:01-C*03:03 | 0.015 |
| A*11:01-C*14:02-B*51:01 | 0.013 | A*11:01-B*40:01 | 0.042 | A*11:01-C*03:04 | 0.049 | B*35:01-C*04:01 | 0.019 |
| A*24:02-C*01:02-B*46:01 | 0.017 | A*11:01-B*46:01 | 0.033 | A*11:01-C*07:02 | 0.070 | B*38:02-C*07:02 | 0.029 |
| A*24:02-C*01:02-B*54:01 | 0.013 | A*11:01-B*51:01 | 0.015 | A*11:01-C*08:01 | 0.019 | B*39:01-C*07:02 | 0.019 |
| A*24:02-C*03:04-B*13:01 | 0.015 | A*11:01-B*54:01 | 0.010 | A*11:01-C*08:04 | 0.011 | B*40:01-C*03:04 | 0.040 |
| A*24:02-C*04:03-B*15:25 | 0.017 | A*11:01-B*55:02 | 0.012 | A*11:01-C*12:02 | 0.014 | B*40:01-C*07:02 | 0.052 |
| A*24:02-C*07:02-B*40:01 | 0.011 | A*24:02-B*13:01 | 0.019 | A*11:01-C*12:03 | 0.011 | B*44:03-C*07:01 | 0.017 |
| A*30:01-C*06:02-B*13:02 | 0.021 | A*24:02-B*15:25 | 0.017 | A*11:01-C*14:02 | 0.010 | B*46:01-C*01:02 | 0.132 |
| A*33:03-C*03:02-B*58:01 | 0.042 | A*24:02-B*35:01 | 0.016 | A*24:02-C*01:02 | 0.032 | B*48:01-C*08:01 | 0.010 |
| A*33:03-C*07:01-B*44:03 | 0.013 | A*24:02-B*40:01 | 0.035 | A*24:02-C*03:03 | 0.016 | B*51:01-C*14:02 | 0.025 |
| A*24:02-B*46:01 | 0.014 | A*24:02-C*03:04 | 0.020 | B*52:01-C*12:02 | 0.022 | ||
| A*24:02-B*54:01 | 0.016 | A*24:02-C*04:01 | 0.028 | B*54:01-C*01:02 | 0.036 | ||
| A*30:01-B*13:02 | 0.027 | A*24:02-C*04:03 | 0.024 | B*55:02-C*01:02 | 0.013 | ||
| A*33:03-B*44:03 | 0.016 | A*24:02-C*07:02 | 0.034 | B*58:01-C*03:02 | 0.054 | ||
| A*33:03-B*58:01 | 0.042 | A*30:01-C*06:02 | 0.021 | ||||
| A*33:03-C*03:02 | 0.041 | ||||||
| A*33:03-C*07:01 | 0.017 |
Two KIR3D and their ligands HLA-A3 and HLA-A11 in Yunnan Han and FYDH.
| KIR3DL2-A3/A11 pair | Yunnan Han ( | FYDH ( | Yunnan Han versus FYDH | ||
|---|---|---|---|---|---|
|
| Frequency |
| Frequency |
| |
| 3DL2+-A3/A11+ | 126 | 0.527 | 53 | 0.570 | 0.540 |
| 3DL2+-A3/A11− | 113 | 0.473 | 40 | 0.430 | 0.540 |
Two KIR3D and their ligands HLA-Bw4 in Yunnan Han and FYDH.
| KIR3DL1-Bw4 pair | Yunnan Han ( | FYDH ( | Yunnan Han versus FYDH | ||
|---|---|---|---|---|---|
|
| Frequency |
| Frequency |
| |
| 3DL1+-Bw4+ | 132 | 0.552 | 51 | 0.554 | 1.000 |
| 3DL1+-Bw4− | 95 | 0.397 | 39 | 0.424 | 0.708 |
| 3DL1−-Bw4+ | 9 | 0.038 | 0 | 0.000 | 0.067 |
| 3DL1−-Bw4− | 3 | 0.013 | 2 | 0.022 | 0.620 |
Combination of two inhibitory (KIR2DL2/3 + HLA-C1 and KIR2DL1 + HLA-C2) and two activating (2DS2 + HLA-C1 and 2DS1 + HLA-C2) receptor-ligand pairs in YNH and FYDH.
| Number of pairs | KIR/HLA pairs |
Yunnan Han ( |
FYDH ( | YNH versus FYDH | ||
|---|---|---|---|---|---|---|
|
| Frequency |
| Frequency |
| ||
| Inhibitory or activating | ||||||
| None | 3 | 0.013 | 0 | 0.000 | 0.562 | |
| One pair | 2DL1 + HLA-C2 | 5 | 0.021 | 1 | 0.011 | 1.000 |
| 2DL2/3 + HLA-C1 | 152 | 0.636 | 66 | 0.710 | 0.247 | |
| 2DS1 + HLA-C2 | 0 | 0.000 | 0 | 0.000 | — | |
| Two pairs | 2DL1 + HLA-C2, 2DL2/3 + HLA-C1 | 42 | 0.176 | 19 | 0.204 | 0.532 |
| 2DL1 + HLA-C2, 2DS1 + HLA-C2 | 4 | 0.017 | 0 | 0.000 | 0.580 | |
| 2DL2/3 + HLA-C1, 2DS1 + HLA-C2 | 0 | 0.000 | 1 | 0.011 | 0.280 | |
| Three pairs | 2DL1 + HLA-C2, 2DL2/3 + HLA-C1, 2DS1 + HLA-C2 | 33 | 0.138 | 6 | 0.065 | 0.086 |
| Inhibitory | ||||||
| One pair | 2DL2/3 + HLA-C1 | 152 | 0.636 | 67 | 0.720 | 0.158 |
| 2DL1 + HLA-C2 | 9 | 0.038 | 1 | 0.011 | 0.294 | |
| Two pairs | 2DL1 + HLA-C2, 2DL2/3 + HLA-C1 | 75 | 0.314 | 25 | 0.269 | 0.506 |
| None | 3 | 0.013 | 0 | 0.000 | 0.562 | |
| Activating | ||||||
| One pair | 2DS1 + HLA-C2 | 37 | 0.155 | 7 | 0.075 | 0.070 |
| None | 202 | 0.845 | 86 | 0.925 | ||